UCL Cancer Institute to Use Natera Liquid Biopsy Tech in Lung Cancer Study | GenomeWeb

NEW YORK (GenomeWeb) – Researchers at the University College London Cancer Institute plan to use Natera's technology to analyze circulating cell-free DNA in a non-small cell lung cancer study with the goal of understanding how the cancers mutate, adapt, and become resistant to therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.